Genetic test for liver copper accumulation in dogs

Patent metadata

Field	Value
Publication number	US-10150997-B2
Application number	US-201214363751-A
Country	US
Kind code	B2
Filing date	Dec 6, 2012
Priority date	Dec 6, 2011
Publication date	Dec 11, 2018
Grant date	Dec 11, 2018

Abstract

The present invention provides a method of testing a dog to determine the susceptibility of the dog to liver copper accumulation, comprising detecting in a sample the presence or absence in the genome of the dog of one or more polymorphisms selected from: (a) Chr22_3167534 (SEQ ID NO: 144), Chr22_3135144 (SEQ ID NO: 145), Chr20_55461150 (SEQ ID NO: 146), ChrX_120879711 (SEQ ID NO: 147), Chr19_6078084 (SEQ ID NO: 148), Chr15_62625262 (SEQ ID NO: 149), Chr14_39437543 (SEQ ID NO: 150), Chr15_62625024 (SEQ ID NO: 151), Chr3_86838677 (SEQ ID NO: 152), Chr24_4011833 (SEQ ID NO: 153), Chr18_60812198 (SEQ ID NO: 154), Chr10_65209946 (SEQ ID NO: 155), and the CGCCCC repeat at chromosome location 22:3135287; (b) one or more polymorphisms in linkage disequilibrium with a said polymorphism (a); and/or (c) Chr32_38904515 (SEQ ID NO: 156), Chr8_4892743 (SEQ ID NO: 157) and Chr8_4880518 (SEQ ID NO: 158).

First claim

The invention claimed is:

1. A method of treating or breeding a dog having genetic inheritance of Labrador Retriever breed, comprising:
(a) genotyping a biological sample obtained from the dog to determine in the genome of the dog the nucleotide present at Chr22_3135144 of Canfam 2.0 genome located in exon 2 of ATP7B gene and optionally the nucleotide present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO: 142); and
(b) administering to the dog a low copper food stuff or a therapeutic amount of a copper chelator if G allele is present at Chr22_3135144 of Canfam 2.0 genome and optionally C allele is present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO: 142), or
breeding the dog if A allele is present at Chr22_3135144 of Canfam 2.0 genome and optionally T allele is present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO:142).

2. The method of claim 1 , further comprising:
genotyping a biological sample obtained from a candidate second dog to determine in the genome of the candidate second dog the nucleotide present at Chr22_3135144 of Canfam 2.0 genome located in exon 2 of ATP7B gene, and optionally the nucleotide present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO: 142); and
retiring the candidate second dog from breeding if G allele is present at Chr22_3135144 of Canfam 2.0 genome and optionally C allele is present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO: 142), or
breeding the candidate second dog if A allele is present at Chr22_3135144 of Canfam 2.0 genome and optionally T allele is present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO: 142).

3. The method of claim 1 , wherein the dog has the G allele present at Chr22_3135144 of Canfam 2.0 genome.

4. The method of claim 1 , wherein the step (a) further comprises inputting to a computer system the genotyping data concerning the nucleotide present at Chr22_3135144 of Canfam 2.0 genome and optionally the nucleotide present at ChrX_63338063 of Canfam 2.0 genome (position 102 of SEQ ID NO: 142).

Assignees

• Mars Inc

Inventors

• Martin Alan James
• Jones Paul Glyn
• Watson Adrian
• Rothuizen Jan
• Fieten Hille
• Leegwater Pieter Antonius Jozef

Classifications

• C12Q1/6806

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12Q2600/156

  Polymorphic or mutational markers · CPC title

• G16B20/00

  ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations · CPC title

• A01K67/02 Primary

  Breeding vertebrates · CPC title

• C12Q1/6883 Primary

  for diseases caused by alterations of genetic material · CPC title